Company Profiles

driven by the PitchBook Platform

advanceCOR

advanceCOR
2012 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$1.02M LATEST DEAL AMOUNT
$10.9M TOTAL AMOUNT RAISED
7 INVESTORS
Description

Developer of medicines for the treatment of cardiovascular diseases. The company develops drugs with the focus on inflammatory mechanisms in atherosclerosis.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
Lochhamer Street 29
Rear Building, Martinsried
82152 Martinsried
Germany

+49 (0)89 8565 2010
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore advanceCOR’s full profile, request a free trial.

advanceCOR Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-May-2016 $1.02M $10.9M Completed Startup
2. Early Stage VC 01-Aug-2015 00.000 000.00 Completed Startup
1. Early Stage VC (Series A) 01-Mar-2013 $8.43M $8.43M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

advanceCOR Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bavarian Research Foundation Other 000 0000 000000 0
Bayern Kapital Venture Capital Minority 000 0000 000000 0
BioM Venture Capital Minority 000 0000 000000 0
Bundesministerium für Bildung und Forschung Government 000 0000 000000 0
HMW Innovations Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

advanceCOR Executive Team (7)

Name Title Board
Seat
Contact
Info
Meinrad Gawaz Co-Founder
Martin Lohse Co-Founder
Roland Jahns Co-Founder
Dorothea Siegel-Axel Co-Founder
Martin Ungerer Co-Founder & Chief Medical Officer
You’re viewing 5 of 7 executives. Get the full list »